AXT's Q3 Revenue Dips, Net Loss Widens by 171% Amid Market Headwinds

TL;DR

**AXTI is bleeding cash with a 171% net loss increase, making it a risky bet despite strategic China investments.**

AI Summary

AXT, Inc. reported a significant decline in revenue and net loss for the nine months ended September 30, 2025, compared to the same period in 2024. Revenue decreased by 12.08% from $74.256 million in 2024 to $65.285 million in 2025. The net loss attributable to AXT, Inc. widened substantially, increasing by 170.99% from $6.536 million in 2024 to $17.712 million in 2025. This resulted in a basic net loss per common share of $0.41 in 2025, up from $0.15 in 2024. Operating expenses saw a modest decrease of 12.49%, from $28.066 million in 2024 to $24.559 million in 2025, primarily driven by a reduction in research and development expenses from $10.410 million to $6.656 million. Gross profit plummeted by 66.98% from $19.428 million in 2024 to $6.416 million in 2025. The company's cash and cash equivalents slightly increased to $23.110 million as of September 30, 2025, from $22.833 million at December 31, 2024, while short-term loans increased by 30.23% to $61.547 million from $47.264 million. The strategic outlook includes potential facility construction at ChaoYang LiMei for additional production capacity, and continued efforts towards Tongmei's IPO on the STAR Market.

Why It Matters

AXT's substantial increase in net loss and revenue decline signals a challenging period for the company, impacting investor confidence and potentially future growth prospects. The widening loss per share from $0.15 to $0.41 could deter new investors and pressure existing shareholders. For employees, sustained losses might lead to cost-cutting measures or hiring freezes, while customers could see impacts on product development or pricing. In the competitive semiconductor materials market, AXT's struggles could allow rivals to gain market share, especially given the significant drop in gross profit, which suggests pricing pressures or increased production costs.

Risk Assessment

Risk Level: high — The company's net loss attributable to AXT, Inc. increased by 170.99% to $17.712 million for the nine months ended September 30, 2025, from $6.536 million in the prior year. Additionally, gross profit decreased by 66.98% to $6.416 million, indicating significant operational challenges and margin compression. Short-term loans also increased by 30.23% to $61.547 million, raising concerns about liquidity and debt management.

Analyst Insight

Investors should exercise extreme caution and consider reducing exposure to AXTI given the substantial increase in net loss and significant decline in gross profit. Monitor the progress of Tongmei's STAR Market IPO closely, as its success could provide a much-needed capital injection and improve the company's financial position, but current fundamentals are weak.

Financial Highlights

debt To Equity

0.46

revenue

$65.285M

operating Margin

-27.8%

total Assets

$334.034M

total Debt

$61.547M

net Income

$(17.712M)

eps

$(0.41)

gross Margin

9.8%

cash Position

$23.110M

revenue Growth

-12.08%

Key Numbers

• $65.285M — Revenue (Decreased by 12.08% for the nine months ended September 30, 2025, compared to $74.256M in 2024.)
• $(17.712M) — Net Loss Attributable to AXT, Inc. (Increased by 170.99% for the nine months ended September 30, 2025, from $(6.536M) in 2024.)
• $(0.41) — Basic Net Loss Per Common Share (Increased from $(0.15) in 2024 for the nine months ended September 30, 2025.)
• $6.416M — Gross Profit (Decreased by 66.98% for the nine months ended September 30, 2025, from $19.428M in 2024.)
• $61.547M — Short-term Loans (Increased by 30.23% as of September 30, 2025, from $47.264M at December 31, 2024.)
• $24.559M — Total Operating Expenses (Decreased by 12.49% for the nine months ended September 30, 2025, from $28.066M in 2024.)
• $6.656M — Research and Development Expenses (Decreased from $10.410M in 2024 for the nine months ended September 30, 2025.)
• $23.110M — Cash and Cash Equivalents (Slightly increased as of September 30, 2025, from $22.833M at December 31, 2024.)
• 46,623,170 — Common Shares Outstanding (As of November 1, 2025.)
• 14.5% — Tongmei Noncontrolling Interests (Total noncontrolling and redeemable noncontrolling interests as of September 30, 2025.)

Key Players & Entities

• AXT, Inc. (company) — registrant
• Tongmei (company) — consolidated subsidiary and IPO candidate
• Shanghai Stock Exchange's Sci-Tech innovAtion boaRd (regulator) — target market for Tongmei IPO
• $65.285 million (dollar_amount) — revenue for nine months ended September 30, 2025
• $17.712 million (dollar_amount) — net loss attributable to AXT, Inc. for nine months ended September 30, 2025
• $6.416 million (dollar_amount) — gross profit for nine months ended September 30, 2025
• $61.547 million (dollar_amount) — short-term loans as of September 30, 2025
• ChaoYang LiMei (company) — location for potential additional production capacity
• 7.28% (dollar_amount) — redeemable noncontrolling interest in Tongmei held by Investors as of January 25, 2021
• 14.5% (dollar_amount) — Tongmei's total noncontrolling and redeemable noncontrolling interests as of September 30, 2025

FAQ

Risk Factors

• Increased Short-Term Debt [high — financial]: Short-term loans increased by 30.23% from $47.264 million at December 31, 2024, to $61.547 million as of September 30, 2025. This significant increase in short-term debt, coupled with a widening net loss, raises concerns about the company's short-term liquidity and its ability to service its debt obligations.
• Deteriorating Profitability [high — financial]: Gross profit decreased by 66.98% from $19.428 million in the nine months ended September 30, 2024, to $6.416 million in the same period of 2025. This, along with a substantial increase in net loss attributable to AXT, Inc. by 170.99% to $17.712 million, indicates severe pressure on the company's core business operations and profitability.
• Declining Revenue [medium — operational]: Revenue for the nine months ended September 30, 2025, decreased by 12.08% to $65.285 million compared to $74.256 million in the prior year. This downward trend in top-line performance suggests potential challenges in market demand, competitive pressures, or execution of sales strategies.
• Reduced R&D Investment [medium — operational]: Research and development expenses were significantly reduced from $10.410 million in the nine months ended September 30, 2024, to $6.656 million in the same period of 2025. While this contributed to lower operating expenses, it could impact future innovation and long-term competitiveness.
• Decreased Cash Position for Operations [medium — financial]: Although cash and cash equivalents slightly increased to $23.110 million from $22.833 million, the company's operating cash flow appears strained given the widening net loss and increased short-term debt. Restricted cash also decreased from $10.978 million to $8.100 million.
• Accumulated Deficit [medium — financial]: The company's accumulated deficit increased from $(43.664) million at December 31, 2024, to $(61.376) million as of September 30, 2025. This indicates a history of net losses that have not been offset by profits.
• Tongmei IPO Uncertainty [low — market]: Continued efforts towards Tongmei's IPO on the STAR Market represent a strategic initiative, but the success and timing of this event are subject to market conditions and regulatory approvals, introducing uncertainty.
• Potential Facility Construction [low — operational]: The strategic outlook includes potential facility construction at ChaoYang LiMei for additional production capacity. This represents a significant capital expenditure and execution risk.

Industry Context

The semiconductor materials industry, where AXT operates, is characterized by high R&D intensity, cyclical demand, and significant capital investment. Key trends include the growing demand for advanced materials in areas like AI, 5G, and electric vehicles, alongside intense global competition and supply chain complexities. Companies in this sector must continuously innovate to meet evolving technological requirements and manage production capacity effectively.

Regulatory Implications

AXT operates in a global market and is subject to various regulations, including those related to international trade, environmental standards, and financial reporting. The company's efforts to pursue an IPO for its subsidiary Tongmei on the STAR Market will require adherence to specific listing and disclosure requirements of that exchange. Compliance with these regulations is crucial to avoid penalties and maintain investor confidence.

What Investors Should Do

1. Monitor revenue trends and gross margin performance closely.
2. Assess the company's debt management strategy.
3. Evaluate the impact of reduced R&D spending on future innovation.
4. Track the progress and outcome of Tongmei's IPO.
5. Analyze the company's cash flow generation and liquidity.

Glossary

Accumulated deficit

The total net losses of a company that have not been offset by net income since its inception. (Indicates the company's historical profitability. AXT's accumulated deficit has widened significantly, reflecting ongoing losses.)

Noncontrolling interests

The portion of equity of a subsidiary that is not attributable to the parent company. (Represents ownership in subsidiaries that AXT does not fully own. The 'Tongmei Noncontrolling Interests' are a significant component.)

Redeemable noncontrolling interests

Equity interests in a subsidiary that are redeemable by the holder, often at a specified price or based on a formula, and are presented outside of permanent equity. (These represent obligations that could require AXT to pay cash or issue stock in the future, impacting liquidity and equity.)

Gross profit

Revenue minus the cost of goods sold. (A key indicator of a company's profitability from its core operations. AXT's gross profit has seen a severe decline.)

Operating expenses

Costs incurred in the normal course of business, excluding cost of goods sold, such as selling, general, and administrative expenses, and research and development. (AXT has reduced its total operating expenses, primarily through R&D cuts, but this has not offset the decline in gross profit.)

Basic net loss per common share

The net loss attributable to common shareholders divided by the weighted-average number of common shares outstanding. (Measures the profitability (or loss) on a per-share basis for common stockholders. AXT's loss per share has significantly worsened.)

Cash and cash equivalents

Short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. (Represents the company's most liquid assets. AXT's cash position has slightly increased, but its overall financial health is concerning.)

Short-term loans

Borrowings that are due within one year. (Indicates the company's short-term debt obligations. AXT has seen a substantial increase in its short-term loans.)

Year-Over-Year Comparison

Compared to the prior year's nine-month period, AXT Inc. has experienced a significant downturn. Revenue has fallen by 12.08% to $65.285 million, and gross profit has plummeted by 66.98% to $6.416 million, indicating severe margin compression. The company's net loss has widened dramatically by 170.99% to $17.712 million, resulting in a higher basic net loss per common share of $0.41. While total operating expenses decreased by 12.49%, this was largely driven by a substantial reduction in R&D spending, which could have long-term implications. Short-term loans have increased by 30.23% to $61.547 million, raising concerns about the company's leverage and liquidity.

Key Financial Figures

• $0.001 — ge on which registered: Common Stock, $0.001 par value AXTI The NASDAQ Stock Mar

Filing Documents

• axti20250930_10q.htm (10-Q) — 2757KB
• ex_854008.htm (EX-31.1) — 14KB
• ex_854009.htm (EX-31.2) — 15KB
• ex_854010.htm (EX-32.1) — 6KB
• ex_854011.htm (EX-32.2) — 7KB
• axti20250630_10qimg001.jpg (GRAPHIC) — 14KB
• 0001437749-25-034843.txt ( ) — 12550KB
• axti-20250930.xsd (EX-101.SCH) — 89KB
• axti-20250930_cal.xml (EX-101.CAL) — 51KB
• axti-20250930_def.xml (EX-101.DEF) — 613KB
• axti-20250930_lab.xml (EX-101.LAB) — 489KB
• axti-20250930_pre.xml (EX-101.PRE) — 660KB
• axti20250930_10q_htm.xml (XML) — 2657KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements (unaudited)

Item 1. Financial Statements (unaudited) Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 3 Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024 4 Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2025 and 2024 5 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 6 Notes To Condensed Consolidated Financial Statements 7

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 31

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 54

Controls and Procedures

Item 4. Controls and Procedures 56

OTHER INFORMATION

PART II. OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 57

Risk Factors

Item 1A. Risk Factors 57

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 84

Defaults upon Senior Securities

Item 3. Defaults upon Senior Securities 84

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 84

Other Information

Item 5. Other Information 85

Exhibits

Item 6. Exhibits 85

Signatures

Signatures 86 2 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements (unaudited)

Item 1. Financial Statements (unaudited) AXT, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in thousands, except per share data) September 30, December 31, 2025 2024 ASSETS Current assets: Cash and cash equivalents $ 23,110 $ 22,833 Restricted cash 8,100 10,978 Accounts receivable, net of allowances for credit losses of $ 141 and $ 147 as of September 30, 2025 and December 31, 2024 33,837 25,640 Inventories 77,656 85,077 Prepaid expenses and other current assets 7,052 13,744 Total current assets 149,755 158,272 Property, plant and equipment, net 159,283 159,721 Operating lease right-of-use assets 2,103 2,479 Other assets 22,893 18,842 Total assets $ 334,034 $ 339,314 LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 10,848 $ 12,356 Accrued liabilities 12,502 14,556 Short-term loans 61,547 47,264 Total current liabilities 84,897 74,176 Noncurrent operating lease liabilities 1,587 1,977 Other long-term liabilities 7,094 8,253 Total liabilities 93,578 84,406 Commitments and contingencies (Note 12) Redeemable noncontrolling interests (Note 18) 38,111 38,577 Stockholders' equity: Preferred stock Series A, $ 0.001 par value; 2,000 shares authorized; 883 shares issued and outstanding as of September 30, 2025 and December 31, 2024 (Liquidation preference of $ 8,184 and $ 8,052 as of September 30, 2025 and December 31, 2024) 3,532 3,532 Common stock, $ 0.001 par value; 70,000 shares authorized; 46,218 and 45,358 shares issued and outstanding as of September 30, 2025 and December 31, 2024 46 45 Additional paid-in capital 243,606 241,514 Accumulated deficit ( 61,376 ) ( 43,664 ) Accumulated other comprehensive loss ( 6,660 ) ( 8,657 ) Total AXT, Inc. stockholders' equity 179,148 192,770 Noncontrolling interests 23,197 23,561 Total stockholders' equity 202,345 216,331 Total liabilities, redeemable noncontroll

View Full Filing

View this 10-Q filing on SEC EDGAR